Blog | Financing the NCD Transition: Why Affordability Innovation Is Central to Sustainable Access in Sub-Saharan Africa 

June 8, 2026

Sub-Saharan Africa's NCD burden is growing faster than the systems designed to manage it. Addressing that gap will depend not only on medicine availability, but on how chronic care is financed.

The Financing Gap Is Already Wide — and Widening

Across the region, structural financing constraints are intensifying. Overall health expenditure averages 3.9–5.8% of GDP, well below the African Union's 15% Abuja target. Foreign aid allocations to health have declined substantially in recent years, with some countries experiencing reductions of up to 49% in external support. Domestic fiscal space remains limited, even as the epidemiological burden of cardiovascular disease, diabetes, cancer, chronic kidney disease, sickle cell disease, hepatitis, respiratory illness, and mental health conditions continues to expand.

The resulting gap is not theoretical. Uganda alone faces an estimated USD 32.98 billion funding gap for NCD prevention and control, and similar shortfalls are evident across the region, where chronic disease management requires lifelong treatment, regular monitoring, and predictable commodity supply.

In this context, households absorb much of the burden. National analyses indicate that approximately one-third of NCD medicine expenditures are paid out-of-pocket, exposing families to catastrophic financial risk. For certain chronic regimens, monthly medicine costs can approach US$97, a level that is economically destabilizing for low-income households. Insurance penetration remains limited; in Uganda, national health insurance coverage was estimated at just 0.8% of the population in 2022, with pilots only recently underway.

The conclusion is hard to avoid: scaling NCD services without addressing affordability will widen inequities and undermine continuity of care.

Key Models of Affordability Innovation

Medical Access' NCD+ Access Strategy is built on a core conviction: financing reform must occur in parallel with supply chain strengthening, not after it. Our approach prioritizes innovative, blended financing mechanisms designed to reduce patient burden while maintaining system sustainability. Key models include:

  • Cost-Plus Inversion Pricing Models: By restructuring price composition around transparent cost layers, including procurement, logistics, and operational margins, this model reduces excessive intermediary markups and improves predictability for both providers and patients.

  • Tiered Co-Payment Structures: Structured contributions based on income bands and disease burden can protect the most vulnerable populations while maintaining cost-recovery mechanisms that ensure supply continuity.

  • Micro-Insurance and Digital Payment Integration: With mobile penetration approaching 80% across Sub-Saharan Africa, digital payment platforms create opportunities to expand prepayment mechanisms, installment-based medicine purchasing, and community-based risk pooling models.

  • Public–Private Partnership Models: This strategy emphasizes collaboration with insurers, development partners, and private pharmacies to co-design sustainable chronic care benefit packages aligned with national Universal Health Coverage frameworks.

Beyond Patient-Level Solutions

Importantly, financing innovation is not limited to patient-level solutions. It also includes strengthening procurement efficiency, optimizing working capital cycles, and leveraging bonded export and warehousing infrastructure to reduce cost volatility across supply chains.

The Urgency of Structural Reform

The broader market landscape reinforces the urgency of reform. Sub-Saharan Africa's population now exceeds 1.2 billion, urbanization is accelerating, and demand for medicines for chronic diseases will continue to grow. Without structured affordability mechanisms, informal markets will expand, counterfeit risks will increase, and adherence will remain inconsistent.

Sustainable NCD control requires moving beyond short-term commodity procurement toward integrated financing ecosystems that align predictable pooled procurement, transparent pricing structures, risk pooling and insurance expansion, digital payment innovation, and patient-centered affordability safeguards.

The transition to chronic disease dominance is not only a clinical and supply chain challenge. It is a financial transformation. Countries that embed affordability innovation into NCD scale-up strategies today will be better positioned to achieve Universal Health Coverage while protecting households from impoverishment.

Medical Access is committed to working with Ministries of Health, insurers, development finance institutions, philanthropic partners, and private sector actors to co-design scalable financing mechanisms that ensure equitable, continuous access to chronic disease care across Sub-Saharan Africa.

Affordability is not an ancillary issue in the NCD response. It is the foundation of sustainable access.